ϳԹ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • ϳԹ News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Aug 3 2026 UPDATED 9:07 AM

Full Issue

New Freeze-Dried Plasma Will Help Rural Residents As Well As Those Injured In War, Disasters

Unlike conventional plasma products, MedPage Today reported, Ezplaz can be stored at room temperature, is stable after exposure to temperature fluctuations, is rapidly reconstituted, and is packaged in a plastic bag rather than a glass bottle. The FDA has licensed it for use when frozen plasma isn't available.

The FDA licensed Ezplaz, the first freeze-dried plasma product available to adults in need of transfusion, on Wednesday. Ezplaz is intended for patients who need plasma -- such as those who are bleeding, need massive transfusion, or are bleeding while on warfarin -- when conventional frozen plasma is not available. (Bassett, 7/29)

On weight loss drugs —

With the promise that GLP-1 drugs, approved for diabetes and weight loss, can also treat ailments such as cancer and heart disease, the government is now exploring if they can reduce alcohol abuse among U.S. military veterans. With an estimated 400,000 U.S. veterans diagnosed with alcohol use disorder, the Department of Veterans Affairs said this week it is launching a randomized clinical trial to measure whether semaglutide, the ingredient in Novo Nordisk’s Ozempic and Wegovy, can reduce drinking and improve quality of life. (Rowland, 7/31)

A new study conducted by leading researchers across the U.S. suggests GLP-1 drugs could have a much greater impact beyond obesity. GLP-1s have become known as something of a go-to weight-loss drug. The research, published in “Diabetes, Obesity, and Metabolism,” illustrated that a variance in dosage or type of drug can impact results. (Djordjevic, 7/31)

News from the healthcare industry —

OSF HealthCare agreed to pay $552,250 as part of a settlement agreement with the Health and Human Services Department’s Office for Civil Rights. After OSF HealthCare filed a breach report in October 2021 related to a ransomware attack, the agency launched an investigation to determine whether the provider had violated the Health Insurance Portability and Accountability Act of 1996. The attack — which OSF HealthCare discovered in April 2021 — exposed the protected health information of 53,907 patients. (DeSilva, 7/31)

The story of Cleveland Clinic’s Avon campus has followed a familiar pattern: Build, grow, repeat. Fifteen years after opening the Richard E. Jacobs Health Center — and a decade after opening Avon Hospital — the Clinic is ready to build again in Avon. On Thursday, July 30, the health system broke ground on a $322 million expansion that will add beds, operating rooms and cancer services to the Avon campus. (Scalzo, 7/31)

Katrina Asselin was a teen mom when she got the idea to become a nurse. She had just given birth to her daughter, six days after her own 18th birthday, when the staff and nurses who helped during her delivery inspired her to pursue the same kind of work. (Richardson, 8/3)

The Geisel School of Medicine’s first female dean starts her tenure Saturday and she’s excited to turn a spotlight onto Dartmouth’s medical school. Jennifer Hunt, 55, comes to Geisel from the University of Florida College of Medicine where she has served as interim dean since 2024. (Shanahan, 8/1)

ϳԹ News: Earlier Lifeline For Rural Hospitals Faces Test Under ‘Big Beautiful’ Law

A century-old hospital near Michigan’s southern border was one of the nation’s first to convert into a new emergency-focused model Congress created to save rural care. Afterward, though, use of Sturgis Hospital’s emergency department fell, according to data collected at the state level. In June, three years after taking the federal lifeline, the hospital closed, leaving residents of Sturgis, a town of about 11,000 people, without critical healthcare. Its leaders had tried “every reasonable option” to remain open, including seeking a buyer, according to a hospital news release. (Tribble and Leys, 8/3)

Also —

Cardiologists see this happen all too often: A patient is waiting in the hospital for a heart transplant, only to be disqualified because their fitness has fallen with each day in bed. Dismayed by such cases, Radha Gopalan, a heart transplant cardiologist at Banner–University Medical Center Phoenix, decided to try a twist on other rehabilitation programs. (Cooney, 8/3)

Hospitals have been quick to adopt artificial intelligence tools for automating note-taking during patient visits, saying they help lower physician burnout and increase revenues. Medical schools, though, are facing a vexing quandary over AI scribes. (Chan, 8/3)

Companies are exploring how robotics could reshape routine clinical care, developing devices to perform everyday tasks such as blood draws and ultrasound scans. Although the technologies are at different stages of maturity, they reflect a broader push by manufacturers to address health systems’ pressing challenges including workforce shortages and the need for safer, more efficient care delivery. (Dubinsky, 7/31)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ϳԹ
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF